Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Qin, Ya-Zhen  [Clear All Filters]
2024
Wu L-X, Zhao M-Y, Yan N, Zhou Y-L, Cao L-M, Qin Y-Z, Jiang Q, Xu L-P, Zhang X-H, Huang X-J, et al. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia. Clin Exp Med. 2024;24(1):56.
Sun Y, Wang X, Chen W-M, Hao Y, Di Li L-, Li J-Y, Sun K, Shi Z-Y, Jiang H, Jiang Q, et al. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia. Hematol Oncol. 2024;42(2):e3264.
2023
Cao L-M, Zhou Y-L, Gale RPeter, Qin Y-Z, Wu L-X, Zhao M-Y, Zhao X-S, Chen Y-H, Wang Y, Jiang H, et al. CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia. Biomol Biomed. 2023.
Sun K, Wang J, Wang Y-Z, Shi Z-Y, Chang Y, Yuan X-Y, Liu Y-R, Jiang H, Jiang Q, Huang X-J, et al. Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis. Int J Lab Hematol. 2023.
2022
Chen H, Xu L-P, Zhang X-H, Wang Y, Chen Y-H, Yan C-H, Cheng Y-F, Han W, Chen Y, Qin Y-Z, et al. Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation. Leuk Res. 2022;121:106930.
2020
Zhang J-M, Xu Y, Gale RP, Wu L-X, Zhang J, Feng Y-H, Qin Y-Z, Jiang H, Jiang Q, Jiang B, et al. DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia. Br J Haematol. 2020.
2019
Qin Y-Z, Wang Y, Xu L-P, Zhang X-H, Zhao X-S, Liu K-Y, Huang X-J. Subgroup Analysis Can Optimize the Relapse Prediction Cutoff Value for WT1 Expression Following Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia. J Mol Diagn. 2019.
2018
Qin Y-Z, Jiang Q, Jiang H, Lai Y-Y, Shi H-X, Chen W-M, Yu L, Huang X-J. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. Br J Haematol. 2018.
Wang Y-Z, Hao L, Chang Y, Jiang Q, Jiang H, Zhang L-P, He L-L, Yuan X-Y, Qin Y-Z, Huang X-J, et al. A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype. Leuk Res. 2018;72:12-19.